0001661181-18-000032.txt : 20181212
0001661181-18-000032.hdr.sgml : 20181212
20181212193604
ACCESSION NUMBER: 0001661181-18-000032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181210
FILED AS OF DATE: 20181212
DATE AS OF CHANGE: 20181212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gillheeney Gary S.
CENTRAL INDEX KEY: 0001757373
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37906
FILM NUMBER: 181231885
MAIL ADDRESS:
STREET 1: C/O ORGANOGENESIS INC.
STREET 2: 85 DAN ROAD
CITY: CANTON
STATE: MA
ZIP: 02021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Organogenesis Holdings Inc.
CENTRAL INDEX KEY: 0001661181
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 85 DAN ROAD
CITY: CANTON
STATE: MA
ZIP: 02021
BUSINESS PHONE: 781-575-0775
MAIL ADDRESS:
STREET 1: 85 DAN ROAD
CITY: CANTON
STATE: MA
ZIP: 02021
FORMER COMPANY:
FORMER CONFORMED NAME: Avista Healthcare Public Acquisition Corp.
DATE OF NAME CHANGE: 20151215
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-12-10
0001661181
Organogenesis Holdings Inc.
ORGO
0001757373
Gillheeney Gary S.
C/O ORGANOGENESIS HOLDINGS INC.
85 DAN ROAD
CANTON
MA
02021
1
1
0
0
President and CEO
Stock Option (Right to Buy)
1.70
2018-12-10
4
A
0
397900
A
2019-07-01
Common Stock
397900
397900
D
Stock Option (Right to Buy)
.99
2018-12-10
4
A
0
704410
A
2023-07-25
Common Stock
704410
704410
D
Stock Option (Right to Buy)
.99
2018-12-10
4
A
0
664804
A
2024-08-21
Common Stock
664804
664804
D
Stock Option (Right to Buy)
.99
2018-12-10
4
A
0
1637631
A
2024-12-08
Common Stock
1637631
1637631
D
100% of the shares subject to this option are fully vested and exercisable.
Received in connection with the Issuer's business combination (the "Merger") with Organogenesis Inc. ("Organogenesis") in accordance with the terms of the Agreement and Plan of Merger dated as of August 17, 2018 among the Issuer, which was then referred to as Avista Healthcare Public Acquisition Corp., Avista Healthcare Merger Sub, Inc. and Organogenesis, in exchange for an option to acquire 196,010 shares of common stock of Organogenesis for $3.45 per share.
The shares underlying the option vested or shall vest 20% annually beginning on January 1, 2016.
Received in connection with the Merger in exchange for an option to acquire 347,000 shares of common stock of Organogenesis for $2.00 per share.
Received in connection with the Merger in exchange for an option to acquire 327,490 shares of common stock of Organogenesis for $2.00 per share.
The shares underlying the option vested or shall vest 20% annually beginning on December 8, 2015.
Received in connection with the Merger in exchange for an option to acquire 806,715 shares of common stock of Organogenesis for $2.00 per share.
/s/ Stacie S. Aarestad, Attorney-in-Fact
2018-12-12